Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
MAT2A-IN-9
Esophageal Adenocarcinoma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Biliary Tract Cancer
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Urinary Bladder Carcinoma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Gastric Adenocarcinoma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Gastroesophageal Cancer
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Mesothelioma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Lung Adenocarcinoma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Pancreatic Neoplasm
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Peritoneal Mesothelioma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Malignant Pleural Mesothelioma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Neoplasm
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Esophageal Squamous Cell Carcinoma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Urothelial Carcinoma
IDEAYA BiosciencesP1CC (43)
Mb-Cart19.1
Acute Lymphoblastic Leukemia
King Hussein Cancer CenterP1CC (43)
Mb-Cart19.1
B-Cell Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbHP1CC (43)
Mb-Cart19.1
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Miltenyi Biomedicine GmbHP1CC (43)
Mb-Cart19.1
Primary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer CenterP1CC (43)
Mbq-167
Breast Neoplasm
MBQ PharmaP1CC (43)
mbs8
Uveal Melanoma
MonTa Biosciences ApSP1CC (43)
MCI
Depressive Disorder
National Institute of Mental Health (NIMH)P1CC (43)
Mdc-Car-Bcma001
Plasma Cell Myeloma
Technische Universität DresdenP1CC (43)
Mdc-Car-Bcma001
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Technische Universität DresdenP1CC (43)
MDG1015
Gastroesophageal Junction Adenocarcinoma
Medigene AGP1CC (43)
MDG1015
Myxoid Liposarcoma
Medigene AGP1CC (43)
MDG1015
Soft Tissue Sarcoma
Medigene AGP1CC (43)
Showing 3251 to 3275 of 9,920 assets
PreviousPage 131 of 397Next